Bluejay Diagnostics, Inc. (BJDX): Capital Expenditures
$173.7K
Year ended 2025-12-31
-47.5%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $173.7K | -43.4% | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | $306.8K | -56.4% | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | $704.2K | -41.3% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $1.20M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $23.9K | n/a | 2023-03-20, From 2021-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | 2025-12-31 | $173.7K | -43.4% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $1.4K | -98.5% |
| Autonomix Medical, Inc. (AMIX) | 2026-03-31 | $10.0K | -28.6% |
| Glucotrack, Inc. (GCTK) | 2025-12-31 | $96.0K | -7.7% |
| Aethlon Medical Inc (AEMD) | 2026-03-31 | $3.7K | n/a |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.0K | -83.3% |
| HeartBeam, Inc. (BEATW) | 2025-12-31 | $600.0K | +198.5% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $103.0K | -37.2% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $185.0K | -73.2% |
Compare BJDX, MDNC, AMIX, GCTK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗